Actor portrayal
Helping you help patients
Primary hyperoxaluria type 1 (PH1) is a rare genetic disorder that can lead to recurrent kidney stones and progressive kidney damage.1,2
How can we help you today?
Access PH1 clinical education
Learn about warning signs, disease progression, and management options.
Explore resource library
Access helpful PH1 treatment-related guidelines.
Learn about PH1 diagnosis
Explore recommended tests and screenings to help diagnose PH1.
What tools & support would help your patients?
education
Patient Resources
Connect eligible patients with affordability and access resources through NovoCare®.
education
Patient Communities
Support patients throughout the treatment journey with helpful organizations and communities below.
What professional education interests you?
Connect with a Novo Nordisk representative
If you have questions about our treatment for PH1, your local representative is here to help.
Actor portrayal
Actor portrayal
Want to give your patients more support?
NovoCare® provides affordability and access support resources to help your patients obtain the medicine that’s right for them.
References:
- Lai C, Pursell N, Gierut J, et al. Specific inhibition of hepatic lactate dehydrogenase reduces oxalate production in mouse models of primary hyperoxaluria. Mol Ther. 2018;26(8):1983-1995. doi:10.1016/ j.ymthe.2018.05.016
- Soliman NA, Nabhan MM, Abdelrahman SM, et al. Clinical spectrum of primary hyperoxaluria type 1: experience of a tertiary center. Nephrol Ther. 2017;13(3):176-182. doi:10.1016/j.nephro.2016.08.002